Lars‐Gunnar Larsson

11.4k total citations · 2 hit papers
130 papers, 8.5k citations indexed

About

Lars‐Gunnar Larsson is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Lars‐Gunnar Larsson has authored 130 papers receiving a total of 8.5k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Molecular Biology, 35 papers in Oncology and 28 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Lars‐Gunnar Larsson's work include Cancer-related Molecular Pathways (21 papers), Ubiquitin and proteasome pathways (14 papers) and Neurotransmitter Receptor Influence on Behavior (12 papers). Lars‐Gunnar Larsson is often cited by papers focused on Cancer-related Molecular Pathways (21 papers), Ubiquitin and proteasome pathways (14 papers) and Neurotransmitter Receptor Influence on Behavior (12 papers). Lars‐Gunnar Larsson collaborates with scholars based in Sweden, Germany and United States. Lars‐Gunnar Larsson's co-authors include Fuad Bahram, Per Hydbring, Anne Lindberg, Bo Lundbäck, Karl‐Johan Leuchowius, Ola Söderberg, Ulf Landegren, Malin Jarvius, Mats Gullberg and Karin Ridderstråle and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Lars‐Gunnar Larsson

125 papers receiving 8.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Direct observation of individual endogenous protein complexes in situ by proximity ligation

2006 1.9k citations Ola Söderberg, Mats Gullberg et al. Nature Methods profile →
Breast cancer screening with mammography: overview of Swedish randomised trials

1993 707 citations Lars‐Gunnar Larsson et al. profile →

Peers

Countries citing papers authored by Lars‐Gunnar Larsson

Since Specialization

Citations

This map shows the geographic impact of Lars‐Gunnar Larsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars‐Gunnar Larsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars‐Gunnar Larsson more than expected).

Fields of papers citing papers by Lars‐Gunnar Larsson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars‐Gunnar Larsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars‐Gunnar Larsson. The network helps show where Lars‐Gunnar Larsson may publish in the future.

Co-authorship network of co-authors of Lars‐Gunnar Larsson

This figure shows the co-authorship network connecting the top 25 collaborators of Lars‐Gunnar Larsson. A scholar is included among the top collaborators of Lars‐Gunnar Larsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars‐Gunnar Larsson. Lars‐Gunnar Larsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	An open-label cluster-randomised trial on TB preventive therapy for children 2025 ·PubMed ·(unknown), Lars‐Gunnar Larsson, Frauke Rudolf, (unknown), Morten Sodemann, V. Gomes, Christian Wejse	0
2	MYCN Amplification Is Associated with Reduced Expression of Genes Encoding γ-Secretase Complex and NOTCH Signaling Components in Neuroblastoma 2023 ·International Journal of Molecular Sciences ·Prasoon Agarwal, (unknown), (unknown), (unknown), Lars‐Gunnar Larsson, Mohammad Alzrigat	5
3	Novel Allosteric Mechanism of Dual p53/MDM2 and p53/MDM4 Inhibition by a Small Molecule 2022 ·Frontiers in Molecular Biosciences ·Vera Grinkevich, (unknown), (unknown), Natalia Issaeva, Virginia Andreotti, (unknown), Elisabeth Hedström, Clemens Spinnler, Alberto Inga, Lars‐Gunnar Larsson, Anders Karlén, Margareta Wilhelm, Perdita E. Barran, Andrei L. Okorokov, Galina Selivanova, Joanna Zawacka‐Pankau	5
4	PTEN and DNA-PK determine sensitivity and recovery in response to WEE1 inhibition in human breast cancer 2020 ·eLife ·(unknown), Aldwin Suryo Rahmanto, Henrik J. Johansson, Marcela Franco, (unknown), (unknown), Oliver Frings, Erik Fredlund, Charles Spruck, Janne Lehtiö, Juha Rantala, Lars‐Gunnar Larsson, Olle Sangfelt	20
5	MYC and RAS are unable to cooperate in overcoming cellular senescence and apoptosis in normal human fibroblasts 2018 ·Cell Cycle ·Fan Zhang, (unknown), Vedrana Tabor, Madhurendra Singh, Susanna Tronnersjö, Jacob Goodwin, Galina Selivanova, Jiří Bártek, Alina Castell, Lars‐Gunnar Larsson	13
6	MYC Synergizes with Activated BRAFV600E in Mouse Lung Tumor Development by Suppressing Senescence 2014 ·Cancer Research ·Vedrana Tabor, Matteo Bocci, Nyosha Alikhani, Raoul Kuiper, Lars‐Gunnar Larsson	17
7	TGF-β enforces senescence in Myc-transformed hematopoietic tumor cells through induction of Mad1 and repression of Myc activity 2009 ·Experimental Cell Research ·Siqin Wu, Anne Hultquist, Per Hydbring, Cihan Cetinkaya, Fredrik Öberg, Lars‐Gunnar Larsson	22
8	Characterizing proteins and their interactions in cells and tissues using the in situ proximity ligation assay 2008 ·Methods ·Ola Söderberg, Karl‐Johan Leuchowius, Mats Gullberg, Malin Jarvius, Irene Weibrecht, Lars‐Gunnar Larsson, Ulf Landegren	425
9	Asthma control over 3 years in a real-life study 2008 ·Respiratory Medicine ·Bo Lundbäck, Eva Rönmark, Anne Lindberg, Ann-Christin Jonsson, Lars‐Gunnar Larsson, Mark James	24
10	Drug‐induced Myc‐mediated apoptosis of cancer cells is inhibited by stress protein Hsp70 2007 ·International Journal of Cancer ·Elena Afanasyeva, Elena Y. Komarova, Lars‐Gunnar Larsson, Fuad Bahram, Boris A. Margulis, Irina V. Guzhova	21
11	Direct observation of individual endogenous protein complexes in situ by proximity ligation breakdown → 2006 ·Nature Methods ·Ola Söderberg, Mats Gullberg, Malin Jarvius, Karin Ridderstråle, Karl‐Johan Leuchowius, Jonas Jarvius, Kenneth Wester, Per Hydbring, Fuad Bahram, Lars‐Gunnar Larsson, Ulf Landegren	1899
12	Control of mild to moderate asthma over 1-year with the combination of salmeterol and fluticasone propionate 2005 ·Respiratory Medicine ·Bo Lundbäck, Eva Rönmark, Anne Lindberg, Ann-Christin Jonsson, Lars‐Gunnar Larsson, Frank Pétavy, Mark James	41
13	Not 15 But 50% of smokers develop COPD?—Report from the Obstructive Lung Disease in Northern Sweden Studies 2003 ·Respiratory Medicine ·Bo Lundbäck, Anne Lindberg, Mikael S. Lindström, Erik Rönmark, Ann-Christin Jonsson, (unknown), Lars‐Gunnar Larsson, Stefan Andersson, Thomas Sandström, Krister Larsson	443
14	Symptoms related to obstructive sleep apnoea are common in subjects with asthma, chronic bronchitis and rhinitis in a general population 2001 ·Respiratory Medicine ·Lars‐Gunnar Larsson, Anne Lindberg, Karl A. Franklin, Bo Lundbäck	112
15	Brachial Plexopathy After Postoperative Radiotherapy of Breast Cancer Patients: A Long-Term Follow-up 2000 ·Acta Oncologica ·Silvia Johansson, H. Svensson, Lars‐Gunnar Larsson, J. Denekamp	67
16	The basic region/helix – loop – helix/leucine zipper domain of Myc proto-oncoproteins: Function and regulation 1999 ·Oncogene ·Bernhard Lüscher, Lars‐Gunnar Larsson	165
17	Synergism between 5-HT1B/1D and 5-HT1A receptor antagonists on turnover and release of 5-HT in guinea-pig brain in vivo 1999 ·Naunyn-Schmiedeberg s Archives of Pharmacology ·Carina Stenfors, (unknown), Lars‐Gunnar Larsson, Hong Yu, (unknown), Ólafur Þ. Magnússon, Svante B. Ross	25
18	Organization Of Radiotherapy And Clinical Oncology In Sweden A Historical Review 1995 ·Acta Oncologica ·Lars‐Gunnar Larsson	2
19	C- Jun is Induced to High Continuous Expression During Differentiation of Hematopoietic Cells and is Regulated Independently from C- Fos 1991 ·Leukemia & lymphoma ·Lars‐Gunnar Larsson, Rein Anton, Irene Ivhed, Fredrik Öberg, Ulf Pettersson, Kenneth Nilsson	4
20	Different effects on the responses of functional pre- and postsynaptic 5-HT1A receptors by repeated treatment of rats with the 5-HT1A receptor agonist 8-OH-DPAT 1990 ·Neuropharmacology ·Lars‐Gunnar Larsson, Lucy Rényi, Svante B. Ross, Birte Svensson, (unknown)	122

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact